Fig. 3From: Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphomaCalibration plot comparing the predicted and actual survival probabilities at 3-year PFS (a), 3-year OS (b), 5-year PFS (c) and 5-year OS (d). PFS, progression-free survival; OS, overall survivalBack to article page